(This Feb. 10 story has been refiled to say 'LOEs (loss of exclusivity),' not 'LOEs (levels of evidence),' in paragraph 13) ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics, according to people familiar with the matter.

Service Canada provides Canadians with a single point of access to a wide range of government services and benefits. Be aware of fraudulent email (phishing), mail and telephone (including text ...

2025 provincial and territorial income tax rates Provincial and territorial tax rates vary across Canada; however, your provincial or territorial income tax (except Quebec) is calculated in the same ...

(RTTNews) - Drug major Merck & Co. (MRK) announced Friday that ... CAPVAXIVE was first approved in the U.S. in June 2024, followed by Canada in July 2024, and Australia in January 2025.

Merck (MRK) announced that the Committee for ... Capvaxive was first approved in the U.S. in June 2024, in Canada in July 2024, and in Australia in January 2025. In addition, capvaxive is ...

Today, a brief rundown of news involving Merck & Co. and AstraZeneca, as well as updates from AbbVie, Stealth BioTherapeutics and Vigil Neuroscience that you may have missed. Aardvark Therapeutics ...

Canada’s population will grow over the years regardless of the federal government’s recent decision to slash immigration rates, a new report shows. Statistics Canada released new projection ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

And today, my film isn't even being allowed to release there).” She added, “Aese hi kuch humlein logo par woh Canada mein ya Britain mein bhi kiye jaraha hai. Kuch chote mote logo ne ...

The recalled products were distributed in British Columbia, Manitoba, Ontario and possibly other provinces and territories in Canada. About Salmonella infections Food contaminated with Salmonella ...

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.